Inventor
LA DANIEL
US25 patents
⚠️ This page may combine multiple inventors who share the name “LA DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
12 patentsUS7435823B2Oct 14, 2008
Compounds and methods of use
AMGEN INC19 citations92
US7872009B2Jan 18, 2011
Beta-Secretase modulators and methods of use
AMGEN INC11 citations82
US9012443B2Apr 21, 2015
Bicyclic aryl and heteroaryl sodium channel inhibitors
AMGEN INC6 citations70
US7973047B2Jul 5, 2011
Beta-Secretase modulators and methods of use
AMGEN INC2 citations61
US7745484B2Jun 29, 2010
Beta-secretase modulators and methods of use
AMGEN INC2 citations60
US9458152B2Oct 4, 2016
Bicyclic sulfonamide compounds as sodium channel inhibitors
AMGEN INC2 citations59
US9212182B2Dec 15, 2015
Bicyclic sulfonamide compounds as sodium channel inhibitors
AMGEN INC3 citations59
US7951838B2May 31, 2011
Substituted spirocyclic chromanamine compounds as Beta-Secretase modulators and methods of use
AMGEN INC0 citations52
US7803809B2Sep 28, 2010
Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
AMGEN INC0 citations51
US7838676B2Nov 23, 2010
Beta-secretase modulators and methods of use
AMGEN INC1 citations50
US10668067B2Jun 2, 2020
Pyridine sulfonamides
AMGEN INC0 citations38
US9346798B2May 24, 2016
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
AMGEN INC0 citations38
SAGE THERAPEUTICS INC
7 patentsUS11926646B2Mar 12, 2024
C7 substituted oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11149056B2Oct 19, 2021
C7 substituted oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations84
US11279730B2Mar 22, 2022
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations73
US10781231B2Sep 22, 2020
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC4 citations73
US12421275B2Sep 23, 2025
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC0 citations62
US12331070B2Jun 17, 2025
C7 substituted oxysterols and methods of use thereof
SAGE THERAPEUTICS INC0 citations62
US11718642B2Aug 8, 2023
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC1 citations62